🇺🇸 FDA
Company

PLIANT

PLIANT THERAPEUTICS, INC.

PLRX pharma USA

Quick answer

PLIANT is a pharma company (PLRX) headquartered in SOUTH SAN FRANCISCO, CA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

PLN-74809

Acute Respiratory Distress Syndrome

Phase 2 · small_molecule · terminated

1 trials project

PLN-74809

Idiopathic Pulmonary Fibrosis

Phase 2 · small_molecule · completed

4 trials project

PLN-74809

Primary Sclerosing Cholangitis

Phase 2 · small_molecule · completed

1 trials project

PLN-101095

Advanced or Metastatic Solid Tumor

Phase 1 · small_molecule · active

1 trials project

[18F]FP-R01-MG-F2

Idiopathic Pulmonary Fibrosis

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12390463

Dosage forms and regimens for amino acid compounds

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12134642

Antibodies binding to α7β1 integrin antibodies and compositions thereof

Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11952376

Substituted amino acids as integrin inhibitors

Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11858931

Amino acid compounds with unbranched linkers and methods of use

Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11673887

N-acyl amino acid compounds and methods of use

Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11634418

Amino acid compounds and methods of use

Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11560376

Amino acid compounds and methods of use

Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11419869

Dosage forms and regimens for amino acid compounds

Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)